DEF 14A

Company

ANI PHARMACEUTICALS INC

Filed

April 6, 2017

Period of Report

May 17, 2017

Accession Number

0001144204-17-019433

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →